Top Markets
Coin of the day
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF
Clasificación en acciones #38709
Genix Pharmaceuticals Corporation, established in 1993 and headquartered in... Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.
Precio por acción
$0.0138
Última sincronización: 2026-08-13
Capitalización bursátil
$844.89K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Genix Pharmaceuticals Corporation (GENPF)

Categoría

EPS de Genix Pharmaceuticals Corporation (GENPF)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Genix Pharmaceuticals Corporation, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Genix Pharmaceuticals Corporation desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras